Physician profile
Belachew Tessema
NPI 1417005000
$45,008.09
in general payments reported to CMS, 2019-2025
13 companies · $43K in 2025
The $43K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $156 · 2021: $28.99 · 2023: $81.37 · 2024: $1,687 · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Travel and Lodging: $3,577 · Consulting Fee: $2,648 · Food and Beverage: $1,867 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,159.90 |
| Travel and Lodging | $3,576.97 |
| Consulting Fee | $2,648.00 |
| Food and Beverage | $1,866.69 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $36,949.71 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $6,888.13 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $368.22 | 2019-2020 | |
| Glaxosmithkline, LLC. | $144.27 | 2024-2025 | Nucala |
| Acclarent, INC | $142.36 | 2019-2024 | Trudi Nav Cable |
| Optinose US, INC. | $111.95 | 2019-2024 | |
| Medtronic, INC. | $103.30 | 2021-2025 | Fusion, Propel, Sinuva |
| Regeneron Pharmaceuticals, INC. | $100.09 | 2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $73.49 | 2020-2025 | |
| Medtronic USA, INC. | $70.85 | 2019 | |
| Stryker Corporation | $22.84 | 2025 | Xpress Loprofile |
| Integra Lifesciences Corporation | $17.02 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Sanofi Pasteur INC. | $15.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Belachew Tessema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.